Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance

BJU International

Volumn 117, Issue 3, 2016, Pages 469-477

  Parker, Patricia A ^a   Davis, John W ^a   Latini, David M ^b   Baum, George ^a   Wang, Xuemei ^a   Ward, John F ^a   Kuban, Deborah ^a   Frank, Steven J ^a   Lee, Andrew K ^a   Logothetis, Christopher J ^a   Kim, Jeri ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

active surveillance; anxiety; fear; prostate cancer; quality of life; watchful waiting

Indexed keywords

STEROID 5ALPHA REDUCTASE INHIBITOR;

ADULT; AGE; AGED; ANXIETY; ARTICLE; BODY MASS; CANCER GROWTH; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SURVEILLANCE; EXPANDED PROSTATE CANCER INDEX COMPOSITE; FEAR; HUMAN; ILLNESS BEHAVIOR; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEXUAL FUNCTION; SHORT FORM 12; ANXIETY DISORDERS; DISEASE COURSE; MIDDLE AGED; PROSTATE TUMOR; PSYCHOLOGY; RISK FACTOR; UNCERTAINTY; VERY ELDERLY; WATCHFUL WAITING;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; DISEASE PROGRESSION; FEAR; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RISK FACTORS; UNCERTAINTY; WATCHFUL WAITING;

EID: 84959469713     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.13099     Document Type: Article

References (53)

1. Dall'Era MA, Cooperberg MR, Chan JM, et al. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer 2008; 112: 1650-9
2. Zerbib M, Zelefsky MJ, Higano CS, et al. Conventional treatments of localized prostate cancer. Urology 2008; 72: S25-35
3. Singer EA, Kaushal A, Turkbey B, et al. Active surveillance for prostate cancer: past, present and future. Curr Opin Oncol 2012; 24: 243-50
4. Venderbos LD, Bokhorst LP, Bangma CH, et al. Active surveillance: oncologic outcome. Curr Opin Urol 2013; 23: 268-72
5. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250-61
6. Soloway MS, Soloway CT, Eldefrawy A, et al. Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment. Eur Urol 2010; 58: 831-5
7. Resnick MJ, Koyama T, Fan KH, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 2013; 368: 436-45
8. Bergman J, Litwin MS. Quality of life in men undergoing active surveillance for localized prostate cancer. J Natl Cancer Inst Monogr 2012; 2012: 242-9
9. van den Bergh RC, Roemeling S, Roobol MJ, et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol 2009; 55: 1-8
10. Warlick C, Trock BJ, Landis P, et al. Delayed versus immediate surgical intervention and prostate cancer outcome. J Natl Cancer Inst 2006; 98: 355-7
11. Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367: 203-13
12. Hayes JH, Ollendorf DA, Pearson SD, et al. Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis. Ann Intern Med 2013; 158: 853-60
13. Bailey DE Jr, Wallace M, Mishel MH. Watching, waiting and uncertainty in prostate cancer. J Clin Nurs 2007; 16: 734-41
14. Wallace M. Uncertainty and quality of life of older men who undergo watchful waiting for prostate cancer. Oncol Nurs Forum 2003; 30: 303-9
15. Xu J, Dailey RK, Eggly S, et al. Men's perspectives on selecting their prostate cancer treatment. J Natl Med Assoc 2011; 103: 468-78
16. van den Bergh RC, Essink-Bot ML, Roobol MJ, et al. Anxiety and distress during active surveillance for early prostate cancer. Cancer 2009; 115: 3868-78
17. Latini DM, Hart SL, Knight SJ, et al. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol 2007; 178: 826-31
18. Watts S, Leydon G, Birch B, et al. Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 2014; 4: e003901
19. Kazer MW, Psutka SP, Latini DM, et al. Psychosocial aspects of active surveillance. Curr Opin Urol 2013; 23: 273-7
20. Bailey DE, Mishel MH, Belyea M, et al. Uncertainty intervention for watchful waiting in prostate cancer. Cancer Nurs 2004; 27: 339-46
21. Kazer MW, Bailey DE Jr, Whittemore R. Out of the black box: expansion of a theory-based intervention to self-manage the uncertainty associated with active surveillance (AS) for prostate cancer. Res Theory Nurs Pract 2010; 24: 101-12
22. Thong MS, Mols F, Kil PJ, et al. Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden. BJU Int 2010; 105: 652-8
23. Bacon CG, Giovannucci E, Testa M, Kawachi I. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 2001; 166: 1804-10
24. Eton DT, Lepore SJ, Helgeson VS. Early quality of life in patients with localized prostate carcinoma: an examination of treatment-related, demographic, and psychosocial factors. Cancer 2001; 92: 1451-9
25. Babaian RJ, Miyashita H, Evans RB, et al. The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age. J Urol 1992; 147: 837-40
26. Babaian RJ, Toi A, Kamoi K, et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000; 163: 152-7
27. Mishel MH. The measurement of uncertainty in illness. Nurs Res 1981; 30: 258-63
28. Mishel MH, Hostetter T, King B, et al. Predictors of psychosocial adjustment in patients newly diagnosed with gynecological cancer. Cancer Nurs 1984; 7: 291-9
29. Bailey DE Jr, Wallace M, Latini DM, et al. Measuring illness uncertainty in men undergoing active surveillance for prostate cancer. Appl Nurs Res 2011; 24: 193-9
30. Spielberger C, Gorsuch R, Lushene R. Manual for the StateTrait Anxiety Inventory, Palo Alto, CA: Consulting Psychologists Press, 1970
31. Cassileth BR, Knuiman MW, Abeloff MD, et al. Anxiety levels in patients randomized to adjuvant therapy versus observation for early breast cancer. J Clin Oncol 1986; 4: 972-4
32. Dropkin MJ. Body image and quality of life after head and neck cancer surgery. Cancer Pract 1999; 7: 309-13
33. Wellisch DK, Hoffman A, Goldman S, et al. Depression and anxiety symptoms in women at high risk for breast cancer: pilot study of a group intervention. Am J Psychiatry 1999; 156: 1644-5
34. Wells ME, McQuellon RP, Hinkle JS, et al. Reducing anxiety in newly diagnosed cancer patients: a pilot program. Cancer Pract 1995; 3: 100-4
35. Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002; 20: 557-66
36. Litwin MS, Hays RD, Fink A, et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998; 36: 1002-12
37. Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000; 56: 899-905
38. Link RE, Su LM, Sullivan W, et al. Health related quality of life before and after laparoscopic radical prostatectomy. J Urol 2005; 173: 175-9
39. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-33
40. Roth AJ, Rosenfeld B, Kornblith AB, et al. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer 2003; 97: 2910-8
41. Roth A, Nelson CJ, Rosenfeld B, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics 2006; 47: 340-7
42. Bauer DJ, Preacher KJ, Gil KM. Conceptualizing and testing random indirect effects and moderated mediation in multilevel models: new procedures and recommendations. Psychol Methods 2006; 11: 142-63
43. Mishel M. Uncertainty in Illness Scales Manual. Chapel Hill, NC: University of North Carolina, 1997
44. Ware JE, Kosinski M, Keller SD. SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales, 3rd edn. Lincoln, RI: Quality Metric Incorporated, 1998
45. Chipman JJ, Sanda MG, Dunn RL, et al. Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice. J Urol 2014; 191: 638-45
46. Dale W, Bilir P, Han M, et al. The role of anxiety in prostate carcinoma: a structured review of the listerature. Cancer 2005; 104: 467-78
47. Fujita K, Landis P, McNeil BK, et al. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol 2009; 182: 2664-9
48. Hilton JF, Blaschko SD, Whitson JM, et al. The impact of serial prostate biopsies on sexual function in men on active surveillance for prostate cancer. J Urol 2012; 188: 1252-8
49. Litwin MS, Gore JL, Kwan L, et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007; 109: 2239-47
50. Oliffe JL, Davison BJ, Pickles T, et al. The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer. Qual Health Res 2009; 19: 432-43
51. Jewett MA, Mattar K, Basiuk J, et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 2011; 60: 39-44
52. Dall-Era MA, Konety BR, Cowan JE, et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 2008; 112: 2664-70
53. Klotz L, Zhang L, Lam A, et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010; 28: 126-31